May 18, 2021

Much advised Wesana Health in the successful closing of its reverse takeover (RTO) of Debut Diamonds Inc. (n/k/a Wesana Health Holdings Inc.) and its public company listing on the Canadian Securities Exchange (CSE). Wesana Health focuses on the development of psilocybin-based treatments that aim to treat individuals who suffer from traumatic brain injury.

Principals David Brown, Matthew Feery, Katherine Bonk Lewis, David Schmidt, and Julia Turk, as well as associates Brian Crump and Madison Schmid, served as advisors to Wesana Health.

In addition to its work in connection with the RTO, the Much team guided Wesana Health as it prepared to be listed on the CSE, which involved, among other things, assistance with the exchange, consolidation, and redesignation of its shares in preparation for the listing. On May 10, the company announced that its shares would commence trading under the ticker symbol "WESA."

"A go-public transaction is a huge moment in any company's journey, and our firm is thrilled to support Wesana Health as it evolves and grows," said Much Chairman David Brown. "Each step better positions the Wesana team to make strides in the areas of patient empowerment and the advancement of psilocybin-based treatments."

In March, Much represented Wesana Health during the successful closing of C$16.1 million in an oversubscribed private placement of subscription receipts through a special purpose financing vehicle ahead of the RTO.

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.